Metastatic Neuroendocrine Carcinoma

Also known as: Neuroendocrine carcinoma metastatic / Neuroendocrine carcinoma, metastatic (morphologic abnormality)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB04690Camptothecin1Active Not Recruiting1
DB00762Irinotecan1Active Not Recruiting1
DB01030Topotecan1Active Not Recruiting1
DB08875Cabozantinib2Active Not Recruiting1
DB09130Copper2Enrolling by Invitation1
DB15873Copper oxodotreotide Cu-642Enrolling by Invitation1
DB14554Dotatate2Enrolling by Invitation1
DB17969Edotreotide2Withdrawn1
DB09502Fludeoxyglucose (18F)2Enrolling by Invitation2
DB06186Ipilimumab2Active Not Recruiting1
DB13982Lutetium Lu-1772Withdrawn1
DB09035Nivolumab2Active Not Recruiting2
DB00853Temozolomide2Active Not Recruiting1